Your search history is turned on.
Date: February 7, 2013 Jurisdictions: British Columbia
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2013 KEDEM PHARMACEUTICALS INC. (Exact name of registrant as specified in its charter) 409 Granville Street, Suite ...
February 6, 2013 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Kedem Pharmaceuticals Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of Kedem Pharmaceuticals In...
Date: January 10, 2013 Jurisdictions: British Columbia
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 4, 2013 KEDEM PHARMACEUTICALS INC. (Exact name of registrant as specified in its charter) 8755 Ash Street, Suite 1 Vanc...
Date: January 8, 2013 Jurisdictions: British Columbia
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q [X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2012 or []TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t...
Exhibit 31.1 Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Hassan Salari, certify that: Dated: December 31, 2012 ex31-1.ht...
Exhibit 31.2 Certification of Principal Financial Officer and Principal Accounting Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Audrey Lew, certify that: Dated: December 31, 2012...
Date: October 17, 2012 Jurisdictions: British Columbia
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 16, 2012 KEDEM PHARMACEUTICALS INC. (Exact name of registrant as specified in its charter) 8755 Ash Street, Suite 1 Vanc...
Date: October 15, 2012 Jurisdictions: British Columbia
file://C:\Documents and Settings\IGS\My Documents\Dropbox\SEC C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q For the quarterly period ended August 31, 2012 or For the transition period from ______________ to________________ Commission file number 000-54455 KEDEM PHARMA...